News
Our latest moves
All
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno raises $100 million to bring artificial intelligence to gene therapy
Press
Stat News
May 6, 2021
Dyno raises $100 million to bring artificial intelligence to gene therapy
Press
Stat News
May 6, 2021
Giant steps: Dyno closes $100M series A round for advanced capsid engineering
Press
BioWorld
May 6, 2021
Giant steps: Dyno closes $100M series A round for advanced capsid engineering
Press
BioWorld
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Announcements
May 9, 2024
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Announcements
May 9, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
May 9, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
May 9, 2024
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
Announcements
May 19, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
Announcements
May 19, 2023
Dyno Therapeutics Named on the Forbes List of America’s Best Startup Employers 2022
Announcements
March 11, 2022
Dyno Therapeutics Named on the Forbes List of America’s Best Startup Employers 2022
Announcements
March 11, 2022
Dyno Therapeutics Named Emerging Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
Announcements
December 6, 2021
Dyno Therapeutics Named Emerging Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
Announcements
December 6, 2021
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Announcements
December 2, 2021
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Announcements
December 2, 2021
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Deep diversification of an AAV capsid protein by machine learning
Publications
Nature Biotechnology
February 11, 2021
Deep diversification of an AAV capsid protein by machine learning
Publications
Nature Biotechnology
February 11, 2021
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
A primer on model-guided exploration of fitness landscapes for biological sequence design
Publications
Arxiv
October 4, 2020
A primer on model-guided exploration of fitness landscapes for biological sequence design
Publications
Arxiv
October 4, 2020
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Publications
Science
November 29, 2019
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Publications
Science
November 29, 2019
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home
Press
Endpoints News
September 22, 2021
The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home
Press
Endpoints News
September 22, 2021
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Press
Business Insider
August 2, 2021
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Press
Business Insider
August 2, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Press
Endpoints News
May 6, 2021